Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators.

Shafi T, Meyer TW, Hostetter TH, Melamed ML, Parekh RS, Hwang S, Banerjee T, Coresh J, Powe NR.

PLoS One. 2015 May 4;10(5):e0126048. doi: 10.1371/journal.pone.0126048. eCollection 2015.

2.

Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.

Shafi T, Sirich TL, Meyer TW, Hostetter TH, Plummer NS, Hwang S, Melamed ML, Banerjee T, Coresh J, Powe NR.

Kidney Int. 2017 Dec;92(6):1484-1492. doi: 10.1016/j.kint.2017.05.012. Epub 2017 Jul 21.

3.

Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators.

Melamed ML, Plantinga L, Shafi T, Parekh R, Meyer TW, Hostetter TH, Coresh J, Powe NR.

BMC Nephrol. 2013 Jun 27;14:134. doi: 10.1186/1471-2369-14-134.

4.

Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion.

Sirich TL, Funk BA, Plummer NS, Hostetter TH, Meyer TW.

J Am Soc Nephrol. 2014 Mar;25(3):615-22. doi: 10.1681/ASN.2013060597. Epub 2013 Nov 14.

5.

Free and total p-cresol sulfate levels and infectious hospitalizations in hemodialysis patients in CHOICE and HEMO.

Banerjee T, Meyer TW, Shafi T, Hostetter TH, Melamed M, Zhu Y, Powe NR.

Medicine (Baltimore). 2017 Feb;96(6):e5799. doi: 10.1097/MD.0000000000005799.

6.

Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients.

Sirich TL, Plummer NS, Gardner CD, Hostetter TH, Meyer TW.

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1603-10. doi: 10.2215/CJN.00490114. Epub 2014 Aug 21.

7.

Contribution of residual function to removal of protein-bound solutes in hemodialysis.

Marquez IO, Tambra S, Luo FY, Li Y, Plummer NS, Hostetter TH, Meyer TW.

Clin J Am Soc Nephrol. 2011 Feb;6(2):290-6. doi: 10.2215/CJN.06100710. Epub 2010 Oct 28.

8.

Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.

Lin CJ, Wu V, Wu PC, Wu CJ.

PLoS One. 2015 Jul 14;10(7):e0132589. doi: 10.1371/journal.pone.0132589. eCollection 2015. Review.

9.

Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis.

Pham NM, Recht NS, Hostetter TH, Meyer TW.

Clin J Am Soc Nephrol. 2008 Jan;3(1):85-90. Epub 2007 Nov 28.

10.

Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort study.

Wu IW, Hsu KH, Hsu HJ, Lee CC, Sun CY, Tsai CJ, Wu MS.

Nephrol Dial Transplant. 2012 Mar;27(3):1169-75. doi: 10.1093/ndt/gfr453. Epub 2011 Sep 2.

PMID:
21891772
11.

Serum β-trace protein and risk of mortality in incident hemodialysis patients.

Shafi T, Parekh RS, Jaar BG, Plantinga LC, Oberai PC, Eckfeldt JH, Levey AS, Powe NR, Coresh J.

Clin J Am Soc Nephrol. 2012 Sep;7(9):1435-45. doi: 10.2215/CJN.02240312. Epub 2012 Jun 28.

12.

Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients.

Lee CT, Hsu CY, Tain YL, Ng HY, Cheng BC, Yang CC, Wu CH, Chiou TT, Lee YT, Liao SC.

Blood Purif. 2014;37(1):76-83. doi: 10.1159/000357641. Epub 2014 Feb 22.

PMID:
24576840
13.

Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up.

Lin CJ, Pan CF, Chuang CK, Liu HL, Sun FJ, Wang TJ, Chen HH, Wu CJ.

Arch Med Res. 2013 Oct;44(7):535-41. doi: 10.1016/j.arcmed.2013.09.007. Epub 2013 Sep 19.

PMID:
24055267
14.

Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.

Shafi T, Hostetter TH, Meyer TW, Hwang S, Hai X, Melamed ML, Banerjee T, Coresh J, Powe NR.

Am J Kidney Dis. 2017 Jul;70(1):48-58. doi: 10.1053/j.ajkd.2016.10.033. Epub 2017 Jan 12.

15.

p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.

Meijers BK, De Loor H, Bammens B, Verbeke K, Vanrenterghem Y, Evenepoel P.

Clin J Am Soc Nephrol. 2009 Dec;4(12):1932-8. doi: 10.2215/CJN.02940509. Epub 2009 Oct 15.

16.

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients.

Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y.

Kidney Int. 2006 Mar;69(6):1081-7.

17.

Numerous protein-bound solutes are cleared by the kidney with high efficiency.

Sirich TL, Aronov PA, Plummer NS, Hostetter TH, Meyer TW.

Kidney Int. 2013 Sep;84(3):585-90. doi: 10.1038/ki.2013.154. Epub 2013 May 1.

18.

The association of uremic toxins and inflammation in hemodialysis patients.

Hsu HJ, Yen CH, Wu IW, Hsu KH, Chen CK, Sun CY, Chou CC, Chen CY, Tsai CJ, Wu MS, Lee CC.

PLoS One. 2014 Jul 22;9(7):e102691. doi: 10.1371/journal.pone.0102691. eCollection 2014.

19.

Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.

Winkelmayer WC, Chang TI, Mitani AA, Wilhelm-Leen ER, Ding V, Chertow GM, Brookhart MA, Goldstein BA.

Am J Kidney Dis. 2015 Jul;66(1):106-13. doi: 10.1053/j.ajkd.2015.02.339. Epub 2015 May 2.

20.

Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.

Sirich TL, Fong K, Larive B, Beck GJ, Chertow GM, Levin NW, Kliger AS, Plummer NS, Meyer TW; Frequent Hemodialysis Network (FHN) Trial Group.

Kidney Int. 2017 May;91(5):1186-1192. doi: 10.1016/j.kint.2016.11.002. Epub 2017 Jan 12.

PMID:
28089366

Supplemental Content

Support Center